display ongoing
results: demonstrated suggested inconclusive safety concern ongoing study
breast cancer - HR positive
la/mBC - HR positive - (neo)adjuvant (NA)la/mBC - HR-positive - 2nd line (L2)
alpelisib based treatment
alpelisib plus fulvestrant SOLAR-1 ... SOLAR-1 ...
alpelisib plus letrozole NEO-ORB ... NEO-ORB ...

Study type:

 

- About us - Contact us - Method - RSS Made with in Lyon - Credits - Privacy policy - Licence Creative Commons